QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Announces $300K Private Placement and Warrant Extension
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company focused on imaging-based products for breast cancer care, announced plans for a non-brokered private placement of up to 1.2 million units at $0.25 each to raise gross proceeds of up to $300,000. Each unit will include one common share and one transferable warrant exercisable at $0.50 for three years. Proceeds will be used for general working capital. The Company also extended the expiry of 2,841,325 warrants issued in September 2023 by one year to September 20, 2026, with all other terms unchanged. The warrant extension remains subject to final…